
|Videos|November 5, 2021
Addressing the Established Understanding of How the Use of Aspirin Impacts the Treatment of Chronic Kidney Disease
Jun Ling Lu, MD, assistant professor, University of Tennessee Health Science Center, addresses the established understanding of how the use of aspirin impacts the treatment of chronic kidney disease.
Advertisement
Pharmacy Times interviewed Jun Ling Lu, MD, assistant professor, Department of Medicine, University of Tennessee Health Science Center, on her presentation at the American Society of Nephrology’s Kidney Week 2021 on the association between long-term aspirin use and the progression of kidney disease.
During the discussion, Lu addressed the established understanding of how the use of aspirin impacts the treatment of chronic kidney disease prior to the results of her research.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Apitegromab-mstn, First Muscle-Targeted SMA Therapy
2
Pharmacists Can Close the LDL Control Gap in Lipid Care
3
Predictive Models Could Address Missing Data in Advanced Prostate Cancer
4
Ivonescimab Significantly Extends OS Over Pembrolizumab in PD-L1-Positive Advanced NSCLC
5




































































































